Vertex Pharmaceuticals
Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
VRTX Key Statistics
VRTX News
Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twi...
There's no guarantee that any stock will deliver positive returns. But the odds look good for these three. Where should I put my money? That's the question eve...
Vertex Pharmaceuticals (VRTX) just revealed a series of milestones for its investigational therapy, povetacicept, as it moves further into late-stage trials for...
Analyst ratings
60%
of 35 ratingsMore VRTX News
H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Vertex Pharmaceuticals today and set a price target of $478.00. Elevate Your Investing Strategy:...
In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Vertex Pharmaceuticals, with a price target of $563.00. Elev...
Vertex Pharmaceuticals recently announced several regulatory milestones for povetacicept, including FDA Breakthrough Therapy Designation and a rolling review fo...